Charles River Laboratories International, Inc (CRL)

Snapshot

Price chart

Recent news filings from the company

These are the company news filings sent to the SEC in the last several months, newest first.

• Company update2026-11-09
• Earnings and results2026-11-04
• Company update2026-09-24
• Earnings and results2026-08-05
• Leadership change and Shareholder vote results2026-05-11
• Earnings and results2026-05-07

Latest filings and news from the company

These links go to the company’s own filings on SEC EDGAR. An 8-K is often how a company announces news.

• Current report (8-K), often a press release or news2026-11-09
• Quarterly report (10-Q)2026-11-04
• Current report (8-K), often a press release or news2026-11-04
• Current report (8-K), often a press release or news2026-09-24
• Annual report (10-K)2026-02-18

About Charles River Laboratories International, Inc

Charles River Laboratories International, Inc is listed on the New York Stock Exchange under the ticker CRL. The SEC classifies its main business as Services-Commercial Physical & Biological Research. Its fiscal year ends on December 27.

What this kind of business does

Drug and biotech companies research, test and sell medicines. Some sell approved products, others work on drugs still in testing.

What to look at

Results depend on trials, approvals and patents. An investor may want to look at what is in the pipeline, when patents end, and how much cash the company has.

Topics

Similar companies

For education only. This is not advice to buy or sell. Figures come from the company’s SEC filings for fiscal years 2022 to 2024 and are shown as filed. Chart provided by TradingView. Always read the company’s own reports.